Cargando…
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies
Chimeric antigen receptors (CARs) repurpose natural signaling components to retarget T cells to refractory cancers but have shown limited efficacy in persistent, recurrent malignancies. Here, we introduce “CAR Pooling”, a multiplexed approach to rapidly identify CAR designs with clinical potential....
Autores principales: | Goodman, Daniel B., Azimi, Camillia S., Kearns, Kendall, Talbot, Alexis, Garakani, Kiavash, Garcia, Julie, Patel, Nisarg, Hwang, Byungjin, Lee, David, Park, Emily, Vykunta, Vivasvan S., Shy, Brian R., Ye, Chun Jimmie, Eyquem, Justin, Marson, Alexander, Bluestone, Jeffrey A., Roybal, Kole T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939256/ https://www.ncbi.nlm.nih.gov/pubmed/36350984 http://dx.doi.org/10.1126/scitranslmed.abm1463 |
Ejemplares similares
-
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes
por: Foss, Dana V., et al.
Publicado: (2023) -
Negative feedback by NUR77/Nr4a1 restrains B cell clonal dominance during early T-dependent immune responses
por: Brooks, Jeremy F., et al.
Publicado: (2021) -
NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting
por: Tan, Corey, et al.
Publicado: (2020) -
Molecular mechanics of Staphylococcus aureus adhesin, CNA, and the inhibition of bacterial adhesion by stretching collagen
por: Madani, Ali, et al.
Publicado: (2017) -
CRISPR–Cas9-mediated nuclear transport and genomic integration of nanostructured genes in human primary cells
por: Lin-Shiao, Enrique, et al.
Publicado: (2022)